학술논문
Tofacitinib, an oral Janus kinase inhibitor, in patients from Mexico with rheumatoid arthritis: Pooled efficacy and safety analyses from Phase 3 and LTE studies
Document Type
Article
Author
Source
In Reumatología clínica (English Edition) January-February 2019 15(1):43-53
Subject
Language
ISSN
2173-5743